Total results = 13
<div class="gs_r" style="z-index:400"><div class="gs_ggs gs_fl"><button type="button" id="gs_ggsB0" class="gs_btnFI gs_in_ib gs_btn_half"><span class="gs_wr"><span class="gs_bg"></span><span class="gs_lbl"></span><span class="gs_ico"></span></span></button><div class="gs_md_wp" id="gs_ggsW0"><a href="http://neuro-oncology.oxfordjournals.org/content/13/4/384.full" class=yC1><span class="gs_ggsL"><span class=gs_ctg2>[HTML]</span> from oxfordjournals.org</span><span class="gs_ggsS">oxfordjournals.org <span class=gs_ctg2>[HTML]</span></span></a></div></div><div class="gs_ri"><h3 class="gs_rt"><a href="http://neuro-oncology.oxfordjournals.org/content/13/4/384.short" class=yC0>Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide</a></h3><div class="gs_a">G Prasad, T Sottero, X Yang&hellip; - Neuro- &hellip;, 2011 - neuro-oncology.oxfordjournals.org</div><div class="gs_rs">Abstract Due to its molecular heterogeneity and infiltrative nature, glioblastoma multiforme <br>(GBM) is notoriously resistant to traditional and experimental therapeutics. To overcome <br>these hurdles, targeted agents have been combined with conventional therapy. We <b> ...</b></div><div class="gs_fl"><a href="/scholar?cites=18070556483298719171&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=13">Cited by 27</a> <a href="/scholar?q=related:w_WmMGGDx_oJ:scholar.google.com/&amp;hl=en&amp;num=13&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="/scholar?cluster=18070556483298719171&amp;hl=en&amp;num=13&amp;as_sdt=0,5&amp;sciodt=0,5">All 5 versions</a> <a onclick="return gs_ocit(event,'w_WmMGGDx_oJ')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:399"><div class="gs_ggs gs_fl"><button type="button" id="gs_ggsB1" class="gs_btnFI gs_in_ib gs_btn_half"><span class="gs_wr"><span class="gs_bg"></span><span class="gs_lbl"></span><span class="gs_ico"></span></span></button><div class="gs_md_wp" id="gs_ggsW1"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3126329/" class=yC3><span class="gs_ggsL"><span class=gs_ctg2>[HTML]</span> from nih.gov</span><span class="gs_ggsS">nih.gov <span class=gs_ctg2>[HTML]</span></span></a></div></div><div class="gs_ri"><h3 class="gs_rt"><a href="http://mcb.asm.org/content/31/8/1710.short" class=yC2>Selective abrogation of BiP/GRP78 blunts activation of NF-ÎºB through the ATF6 branch of the UPR: involvement of C/EBPÎ² and mTOR-dependent dephosphorylation  &hellip;</a></h3><div class="gs_a">S Nakajima, N Hiramatsu, K Hayakawa&hellip; - &hellip;  and cellular biology, 2011 - Am Soc Microbiol</div><div class="gs_rs">ABSTRACT Subtilase cytotoxin (SubAB) that selectively cleaves BiP/GRP78 triggers the <br>unfolded protein response (UPR) and protects mice from endotoxic lethality and collagen <br>arthritis. We found that pretreatment of cells with SubAB suppressed tumor necrosis alpha <b> ...</b></div><div class="gs_fl"><a href="/scholar?cites=7992806311679555129&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=13">Cited by 16</a> <a href="/scholar?q=related:OfYoJv4m7G4J:scholar.google.com/&amp;hl=en&amp;num=13&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="/scholar?cluster=7992806311679555129&amp;hl=en&amp;num=13&amp;as_sdt=0,5&amp;sciodt=0,5">All 7 versions</a> <a onclick="return gs_ocit(event,'OfYoJv4m7G4J')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:398"><div class="gs_ri"><h3 class="gs_rt"><a href="http://www.tandfonline.com/doi/abs/10.1080/01635581.2010.509538" class=yC4>Chemopreventive potential of natural compounds in head and neck cancer</a></h3><div class="gs_a">MA Rahman, ARMR Amin, <a href="/citations?user=VIT_03oAAAAJ&amp;hl=en&amp;oi=sra">DM Shin</a> - Nutrition and cancer, 2010 - Taylor &amp; Francis</div><div class="gs_rs">Head and neck squamous cell carcinoma (HNSCC) is one of the most fatal cancers <br>worldwide. Despite advances in the management of HNSCC, the overall survival for patients <br>has not improved significantly due to advanced stages at diagnosis, high recurrence rate <b> ...</b></div><div class="gs_fl"><a href="/scholar?cites=2497133378049026035&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=13">Cited by 13</a> <a href="/scholar?q=related:8ydis5OZpyIJ:scholar.google.com/&amp;hl=en&amp;num=13&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="/scholar?cluster=2497133378049026035&amp;hl=en&amp;num=13&amp;as_sdt=0,5&amp;sciodt=0,5">All 3 versions</a> <a onclick="return gs_ocit(event,'8ydis5OZpyIJ')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:397"><div class="gs_ri"><h3 class="gs_rt"><a href="http://www.sciencedirect.com/science/article/pii/S026643561100043X" class=yC5>A synopsis of head and neck oncology and related papers published in the British Journal of Oral and Maxillofacial Surgery in 2009/10</a></h3><div class="gs_a">A Gulati, MK Herd, J Blythe, A Habib, R Anand&hellip; - British Journal of Oral  &hellip;, 2011 - Elsevier</div><div class="gs_rs">This review summarises all head and neck oncology and related papers published in the <br>British Journal of Oral and Maxillofacial Surgery (BJOMS) during the period 2009â2010. A <br>similar review, covering the years 2007â2008 was published in the Journal in 2009 and <b> ...</b></div><div class="gs_fl"><a href="/scholar?cites=6758095645925954376&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=13">Cited by 3</a> <a href="/scholar?q=related:SNOHHS-UyV0J:scholar.google.com/&amp;hl=en&amp;num=13&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="/scholar?cluster=6758095645925954376&amp;hl=en&amp;num=13&amp;as_sdt=0,5&amp;sciodt=0,5">All 5 versions</a> <a onclick="return gs_ocit(event,'SNOHHS-UyV0J')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:396"><div class="gs_ggs gs_fl"><button type="button" id="gs_ggsB4" class="gs_btnFI gs_in_ib gs_btn_half"><span class="gs_wr"><span class="gs_bg"></span><span class="gs_lbl"></span><span class="gs_ico"></span></span></button><div class="gs_md_wp" id="gs_ggsW4"><a href="http://dx.plos.org/10.1371/journal.pone.0021119" class=yC7><span class="gs_ggsL"><span class=gs_ctg2>[HTML]</span> from plos.org</span><span class="gs_ggsS">plos.org <span class=gs_ctg2>[HTML]</span></span></a></div></div><div class="gs_ri"><h3 class="gs_rt"><span class="gs_ctc"><span class="gs_ct1">[HTML]</span><span class="gs_ct2">[HTML]</span></span> <a href="http://dx.plos.org/10.1371/journal.pone.0021119" class=yC6>CCL21/CCR7 promotes G2/M phase progression via the ERK pathway in human non-small cell lung cancer cells</a></h3><div class="gs_a">Y Xu, L Liu, X Qiu, L Jiang, B Huang, H Li, Z Li, W Luo&hellip; - PloS one, 2011 - dx.plos.org</div><div class="gs_rs">CC chemokine receptor 7 (CCR7) contributes to the survival of certain cancer cell lines, but <br>its role in the proliferation of human non-small cell lung cancer (NSCLC) cells remains <br>vague. Proliferation assays performed on A549 and H460 NSCLC cells using Cell <b> ...</b></div><div class="gs_fl"><a href="/scholar?cites=11464658177196747110&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=13">Cited by 5</a> <a href="/scholar?q=related:ZukWq96lGp8J:scholar.google.com/&amp;hl=en&amp;num=13&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="/scholar?cluster=11464658177196747110&amp;hl=en&amp;num=13&amp;as_sdt=0,5&amp;sciodt=0,5">All 6 versions</a> <a onclick="return gs_ocit(event,'ZukWq96lGp8J')" href="#" class="gs_nph">Cite</a> <div class="gs_rm_dd gs_nph"><a href="#" class="gs_rm_l" onclick="return gs_md_opn('gs_rm_md4', event)">More<span class="gs_ico"></span></a><div id="gs_rm_md4" class="gs_md_wn" style="display:none"><a href="http://scholar.googleusercontent.com/scholar?q=cache:ZukWq96lGp8J:scholar.google.com/&amp;hl=en&amp;num=13&amp;as_sdt=0,5&amp;sciodt=0,5" class="gs_md_li">Cached</a></div>  </div>  </div></div></div>
<div class="gs_r" style="z-index:395"><div class="gs_ri"><h3 class="gs_rt"><a href="http://www.sciencedirect.com/science/article/pii/S0266435611004694" class=yC8>What are we reading? A study of downloaded and cited articles from the British Journal of Oral and Maxillofacial Surgery in 2010</a></h3><div class="gs_a">PA Brennan, A Habib - British Journal of Oral and Maxillofacial Surgery, 2011 - Elsevier</div><div class="gs_rs">A large number of papers related to oral and maxillofacial surgery are published in many <br>specialist journals. With the ever-increasing use of the internet it is easy to download them <br>as part of a journal subscription on a fee per paper basis, or in some cases for free. Online <b> ...</b></div><div class="gs_fl"><a href="/scholar?cites=892311796664373275&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=13">Cited by 3</a> <a href="/scholar?q=related:GxAS9dkgYgwJ:scholar.google.com/&amp;hl=en&amp;num=13&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="/scholar?cluster=892311796664373275&amp;hl=en&amp;num=13&amp;as_sdt=0,5&amp;sciodt=0,5">All 5 versions</a> <a onclick="return gs_ocit(event,'GxAS9dkgYgwJ')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:394"><div class="gs_ggs gs_fl"><button type="button" id="gs_ggsB6" class="gs_btnFI gs_in_ib gs_btn_half"><span class="gs_wr"><span class="gs_bg"></span><span class="gs_lbl"></span><span class="gs_ico"></span></span></button><div class="gs_md_wp" id="gs_ggsW6"><a href="http://www.tara.tcd.ie/jspui/bitstream/2262/61454/1/PEER_stage2_10.1111%252Fj.1365-2559.2011.03864.x.pdf" class=yCA><span class="gs_ggsL"><span class=gs_ctg2>[PDF]</span> from tcd.ie</span><span class="gs_ggsS">tcd.ie <span class=gs_ctg2>[PDF]</span></span></a></div></div><div class="gs_ri"><h3 class="gs_rt"><a href="http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2559.2011.03864.x/full" class=yC9>Mammalian target of rapamycin expression and laryngeal squamous cell carcinoma prognosis: novel preliminary evidence</a></h3><div class="gs_a">G Marioni, A Staffieri, L Giacomelli, M Lionello&hellip; -  &hellip;, 2011 - Wiley Online Library</div><div class="gs_rs">Aims: The mammalian target of rapamycin (mTOR) has a key role in regulating cancer cell <br>proliferation, apoptosis, cell migration, and angiogenesis. The aim of this study was to <br>assess the relationships between mTOR and clinicopathological and prognostic <b> ...</b></div><div class="gs_fl"><a href="/scholar?cites=7669386739536728648&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=13">Cited by 4</a> <a href="/scholar?q=related:SJIt_5oib2oJ:scholar.google.com/&amp;hl=en&amp;num=13&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="/scholar?cluster=7669386739536728648&amp;hl=en&amp;num=13&amp;as_sdt=0,5&amp;sciodt=0,5">All 7 versions</a> <a onclick="return gs_ocit(event,'SJIt_5oib2oJ')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:393"><div class="gs_ggs gs_fl"><button type="button" id="gs_ggsB7" class="gs_btnFI gs_in_ib gs_btn_half"><span class="gs_wr"><span class="gs_bg"></span><span class="gs_lbl"></span><span class="gs_ico"></span></span></button><div class="gs_md_wp" id="gs_ggsW7"><a href="http://mct.aacrjournals.org/content/10/12/2437.full" class=yCC><span class="gs_ggsL"><span class=gs_ctg2>[HTML]</span> from aacrjournals.org</span><span class="gs_ggsS">aacrjournals.org <span class=gs_ctg2>[HTML]</span></span></a></div></div><div class="gs_ri"><h3 class="gs_rt"><a href="http://mct.aacrjournals.org/content/10/12/2437.short" class=yCB>Akt/mTOR Counteract the Antitumor Activities of Cixutumumab, an Anti-Insulinâlike Growth Factor I Receptor Monoclonal Antibody</a></h3><div class="gs_a">DH Shin, HY Min, AK El-Naggar, SM Lippman&hellip; - Molecular cancer  &hellip;, 2011 - AACR</div><div class="gs_rs">Abstract Recent reports have shown limited anticancer therapeutic efficacy of insulin-like <br>growth factor receptor (IGF-1R)-targeted monoclonal antibodies (mAb), but the resistance <br>mechanisms have not been completely identified. Because cooperation between <b> ...</b></div><div class="gs_fl"><a href="/scholar?cites=10653569367336711735&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=13">Cited by 1</a> <a href="/scholar?q=related:N3YWAuUU2ZMJ:scholar.google.com/&amp;hl=en&amp;num=13&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="/scholar?cluster=10653569367336711735&amp;hl=en&amp;num=13&amp;as_sdt=0,5&amp;sciodt=0,5">All 4 versions</a> <a onclick="return gs_ocit(event,'N3YWAuUU2ZMJ')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:392"><div class="gs_ri"><h3 class="gs_rt"><a href="http://www.springerlink.com/index/TR27616835114538.pdf" class=yCD>PKCÎ± take part in CCR7/NF-ÎºB autocrine signaling loop in CCR7-positive squamous cell carcinoma of head and neck</a></h3><div class="gs_a">Z Zhen-jin, L Peng, L Fa-yu, S Liyan&hellip; - Molecular and cellular  &hellip;, 2011 - Springer</div><div class="gs_rs">Abstract Metastatic squamous cell carcinoma of head and neck (SCCHN) has been shown <br>to express chemokine receptor 7 (CCR7). The role of nuclear factor-ÎºB (NF-ÎºB) in <br>propagating an autocrine signaling loop in CCR7-positive SCCHN cells may provide a <b> ...</b></div><div class="gs_fl"><a href="/scholar?cites=7712166821213337488&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=13">Cited by 2</a> <a href="/scholar?q=related:kHf58tweB2sJ:scholar.google.com/&amp;hl=en&amp;num=13&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="/scholar?cluster=7712166821213337488&amp;hl=en&amp;num=13&amp;as_sdt=0,5&amp;sciodt=0,5">All 4 versions</a> <a onclick="return gs_ocit(event,'kHf58tweB2sJ')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:391"><div class="gs_ri"><h3 class="gs_rt"><a href="http://www.sciencedirect.com/science/article/pii/S0266435612005347" class=yCE>Full length articles published in BJOMS during 2010â11âan analysis by sub-specialty and study type</a></h3><div class="gs_a">G Arakeri, S Colbert, G Rosenbaum&hellip; - British Journal of Oral and  &hellip;, 2012 - Elsevier</div><div class="gs_rs">Abstract Full length articles such as prospective and retrospective studies, case series, <br>laboratory-based research and reviews form the majority of papers published in the British <br>Journal of Oral and Maxillofacial Surgery (BJOMS). We were interested to evaluate the <b> ...</b></div><div class="gs_fl"><a href="/scholar?q=related:MmJNQ-Kr-CAJ:scholar.google.com/&amp;hl=en&amp;num=13&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a onclick="return gs_ocit(event,'MmJNQ-Kr-CAJ')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:390"><div class="gs_ggs gs_fl"><button type="button" id="gs_ggsB10" class="gs_btnFI gs_in_ib gs_btn_half"><span class="gs_wr"><span class="gs_bg"></span><span class="gs_lbl"></span><span class="gs_ico"></span></span></button><div class="gs_md_wp" id="gs_ggsW10"><a href="http://dx.plos.org/10.1371/journal.pone.0033262" class=yC10><span class="gs_ggsL"><span class=gs_ctg2>[HTML]</span> from plos.org</span><span class="gs_ggsS">plos.org <span class=gs_ctg2>[HTML]</span></span></a></div></div><div class="gs_ri"><h3 class="gs_rt"><span class="gs_ctc"><span class="gs_ct1">[HTML]</span><span class="gs_ct2">[HTML]</span></span> <a href="http://dx.plos.org/10.1371/journal.pone.0033262" class=yCF>CCL21/CCR7 Prevents Apoptosis via the ERK Pathway in Human Non-Small Cell Lung Cancer Cells</a></h3><div class="gs_a">Y Xu, L Liu, X Qiu, Z Liu, H Li, Z Li, W Luo, E Wang - PloS one, 2012 - dx.plos.org</div><div class="gs_rs">Previously, we confirmed that CC chemokine receptor 7 (CCR7) promotes cell proliferation <br>via the extracellular signal-regulated kinase (ERK) pathway, but its role in apoptosis of non-<br>small cell lung cancer (NSCLC) cell lines remains unknown. A549 and H460 cells of <b> ...</b></div><div class="gs_fl"><a href="/scholar?q=related:N-saU-Yz7OYJ:scholar.google.com/&amp;hl=en&amp;num=13&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="/scholar?cluster=16639731787556907831&amp;hl=en&amp;num=13&amp;as_sdt=0,5&amp;sciodt=0,5">All 5 versions</a> <a onclick="return gs_ocit(event,'N-saU-Yz7OYJ')" href="#" class="gs_nph">Cite</a> <div class="gs_rm_dd gs_nph"><a href="#" class="gs_rm_l" onclick="return gs_md_opn('gs_rm_md10', event)">More<span class="gs_ico"></span></a><div id="gs_rm_md10" class="gs_md_wn" style="display:none"><a href="http://scholar.googleusercontent.com/scholar?q=cache:N-saU-Yz7OYJ:scholar.google.com/&amp;hl=en&amp;num=13&amp;as_sdt=0,5&amp;sciodt=0,5" class="gs_md_li">Cached</a></div>  </div>  </div></div></div>
<div class="gs_r" style="z-index:389"><div class="gs_ggs gs_fl"><button type="button" id="gs_ggsB11" class="gs_btnFI gs_in_ib gs_btn_half"><span class="gs_wr"><span class="gs_bg"></span><span class="gs_lbl"></span><span class="gs_ico"></span></span></button><div class="gs_md_wp" id="gs_ggsW11"><a href="http://mct.aacrjournals.org/content/early/2011/10/06/1535-7163.MCT-11-0235.full.pdf" class=yC12><span class="gs_ggsL"><span class=gs_ctg2>[PDF]</span> from aacrjournals.org</span><span class="gs_ggsS">aacrjournals.org <span class=gs_ctg2>[PDF]</span></span></a></div></div><div class="gs_ri"><h3 class="gs_rt"><a href="http://mct.aacrjournals.org/content/early/2011/10/06/1535-7163.MCT-11-0235.short" class=yC11>Akt/mammalian target of rapamycin counteract the antitumor activities of cixutumumab an anti-insulin-like growth factor I receptor monoclonal antibody</a></h3><div class="gs_a">DH Shin, HY Min, AK El-Naggar, SM Lippman&hellip; - Molecular Cancer  &hellip;, 2011 - AACR</div><div class="gs_rs">Abstract Recent reports have shown limited anticancer therapeutic efficacy of insulin-like <br>growth factor receptor (IGF-1R)-targeted monoclonal antibodies (mAbs), but the resistance <br>mechanisms have not been completely identified. Because cooperation between <b> ...</b></div><div class="gs_fl"><a href="/scholar?q=related:RukbrmsP8CoJ:scholar.google.com/&amp;hl=en&amp;num=13&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a onclick="return gs_ocit(event,'RukbrmsP8CoJ')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:388"><div class="gs_ri"><h3 class="gs_rt"><a href="http://www.cqvip.com/qk/90052x/201104/37701557.html" class=yC13>é·å¸éç´ èåé¡ºéå¯¹ CCL19 è°èå¤´é¢é³ç¶ç»èçç»èæ´»æ§çå½±å</a></h3><div class="gs_a">åæ³æ±ï¼ èµµéé¦ï¼ æé¹ï¼ ä¸éªï¼ å­é¿ä¼ - ä¸­åå£èå»å­¦æå¿, 2011 - cqvip.com</div><div class="gs_rs">ç®çæ¢è®¨é·å¸éç´ (rapamycin) ä¸é¡ºé(cisplatin) èåä½¿ç¨å¯¹è¶åå å­CCL19 <br>è°èå¤´é¢é³ç¶ç»èçç»èæ´»æ§çå½±å. æ¹æ³åºç¨ç²åºå»ååºåå(MTT) æ³åæµå¼ç»èä»ªæ£æµé¡ºé<br>åé·å¸éç´ å¯¹CCL19 è¯±å¯¼åäººå¤´é¢é³ç¶ç»èçæ·å·´ç»è½¬ç§»ç»èç³»(PCI-4B, PCI-37B) çé¿<b> ...</b></div><div class="gs_fl"><a href="/scholar?q=related:GVornWJ19l8J:scholar.google.com/&amp;hl=en&amp;num=13&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="/scholar?cluster=6914843344278084121&amp;hl=en&amp;num=13&amp;as_sdt=0,5&amp;sciodt=0,5">All 2 versions</a> <a onclick="return gs_ocit(event,'GVornWJ19l8J')" href="#" class="gs_nph">Cite</a></div></div></div>
